TRIANA BIOMEDICINES
Live / Registered — Registered (as of 27 Oct 2026)
What this means for you
Registered since 27 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 97278196
- Registration number
- 8524259
- Mark type
- Word mark
- Filed
- 22 Feb 2022
- Published for opposition
- 18 Jul 2023
- Registered
- 27 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 27 Oct 2032 (grace period to 27 Apr 2033)
- Attorney of record
- Karen K. Won
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of conditions and diseases in the fields of cancer and immunology
- Class 042 — Scientific and technological services: research and development in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases; scientific research in the nature of conducting medical and scientific research, namely, conducting clinical trials for others in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases
Owner
- Triana Biomedicines, Inc., Lexington, MA, US
- Triana Biomedicines, Inc., Lexington, MA, US
- Triana Biomedicines, Inc., Waltham, MA, US
Prosecution history
- 27 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 02 Oct 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 02 Oct 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Oct 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Oct 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Sept 2026 — USE AMENDMENT FILED
- 08 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 12 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2026 — SOU EXTENSION 5 GRANTED
- 11 Dec 2025 — SOU EXTENSION 5 FILED
- 12 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL